Tilray | TRLY - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Acasti Pharma USD 1.28M 39K 2025-12
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Canopy Growth CAD 158.44M 60.15M 2026-03
Cronos Group USD 42.42M 5.77M 2026-03
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 2.4B 408M 2026-03
Organigram Holdings CAD 88.74M 5.31M 2026-03
Organon & Co USD 2.5B 110M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 6.81B 284M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03
Zealand Pharma A/S 664.96M 513.61M 2025-12